Grosso champions greater access to D.C.’s medical marijuana program

For Immediate Release:
January 22, 2019
 
Contact:
Matthew Nocella, 202.724.8105 - mnocella@dccouncil.us

Grosso champions greater access to D.C.’s medical marijuana program

Washington, D.C. – Councilmember David Grosso (I-At Large) today introduced legislation that would further improve access to the District of Columbia’s medical marijuana program for residents as another method of reducing opioid-related deaths.

“We are all concerned with the ongoing tragedy of D.C. residents dying from opioid overdoses and this legislation provides another tool to address that crisis: greater access to the District’s medical marijuana program,” said Grosso.

Since 2014, over 800 people have died as result of opioid-related overdoses, according to the D.C. Chief Medical Examiner. Two hundred and seventy-nine of those deaths were reported in 2017 alone, more than triple those reported in 2014.

Under the Medical Marijuana Patient Health and Accessibility Improvement Amendment Act of 2019 patients would be granted provisional registration and same-day access to medical marijuana like any other medicine.

Additionally, dispensaries would be allowed to establish safe use facilities so that patients can consume medical marijuana outside of their home, which would address the challenge that many patients face of having nowhere to consume.

Finally, the legislation also removes the plant count limit on cultivation centers to address ongoing supply issues and seeks to rectify negative impacts of the racist War on Drugs by allowing more residents affected by the misguided criminalization of marijuana to be employed in these businesses.

“Medical marijuana has been shown to be a viable alternative to the prescription of opioid painkillers, which can set people down the path to addiction,” Grosso said. “While we have made significant improvements to our medical marijuana program here in D.C., we can do more to improve access for patients and reduce opioid reliance and overdose.”

A study in JAMA Internal Medicine found that medical marijuana programs reduce opioid overdose death rates by as much as 25 percent. Americans for Safe Access also reported lower prescription rates of painkillers in states with medical marijuana programs.

Grosso also views the legislation as an appropriate response the negative effects of congressional interference with D.C.’s local efforts to regulate marijuana.

“D.C. residents are being diverted from the medical marijuana program to the unregulated, easy to access, underground market,” Grosso said. “That is posing real problems for the small business owners in the medical marijuana community, and our whole medical marijuana system could be in jeopardy if we don’t take action.”

Councilmembers Vincent Gray and Brianne Nadeau joined Grosso as co-introducers of the legislation.

###

Medical Marijuana Patient Health and Accessibility Improvement Amendment Act of 2019

Medical Marijuana Patient Health and Accessibility Improvement Amendment Act of 2019

Introduced: January 22, 2019

Co-introducers: Councilmembers Vincent Gray and Brianne K. Nadeau

BILL TEXT | PRESS RELEASE

Summary: To amend the Legalization of Marijuana for Medical Treatment Initiative of 1998 to authorize the dispensation of medical marijuana to and use by qualifying patients over the age of 21 at safe-use facilities, to allow qualifying patients, upon application to the Mayor for a medical marijuana registration identification card, to immediately purchase medical marijuana on a provisional basis, subject to the approval or rejection of a registration application, to eliminate the limit on the number of marijuana plants that cultivation centers are permitted to grow, and to allow for the delivery of medical marijuana to qualified patients.

Councilmember Grosso's Introduction Statement:

Today I am introducing the Medical Marijuana Patient Health and Accessibility Improvement Amendment Act of 2019.

We are all concerned with the ongoing tragedy of D.C. residents dying from opioid overdoses—this bill is another part of the effort to stop that crisis.

Research shows that states with robust medical marijuana programs have lower rates of opioid overdose deaths.

While we have made significant improvements to our medical marijuana program over the past few years, there is more we can do to expand access for patients, and bring more people into the regulated market.

This bill would allow for same day access to medical marijuana just like any other medicine by allowing for a provisional registration when a patient submits their paperwork to the Department of Health.

The bill would allow dispensaries to establish safe use facilities so that patients can consume medical marijuana outside of their home, which would address the challenge that many patients face of having nowhere to consume.

There are a number of other improvements to the program as well, such as removing the plant count limit, and allowing more residents affected by the war on drugs to be employed in these businesses.

Improving access makes sense when we are in the midst of an opioid overdose crisis, but it also is an appropriate response to the challenges we face as a result of congressional interference with our local efforts to regulate marijuana.

Due to Representative Harris’ rider on our budget, residents are being diverted from the medical marijuana program to the unregulated, easy to access, underground market.

That is posing real problems for the small business owners in the medical marijuana community, and our whole medical marijuana system could be in jeopardy if we don’t take action.

DOH, DBH responds to Grosso letter regarding safe injection sites to combat the opioid crisis

Councilmember David Grosso received a letter from Department of Health Director Dr. LaQuandra Nesbitt and Department of Behavioral Health Director Dr. Tanya Royster in response to his Sept. 19 letter urging exploration of supervised injection facilities (SIFs) as part of a comprehensive public health approach to combating the opioid crisis and saving lives in the District of Columbia.

DOH/DBH's letter details Dr. Nesbitt's findings from a recent site-visit to a SIF in Vancouver. SIFs there have led to a decrease in opioid-related deaths and, to date, have not experienced an overdose related death on-premises. 

DOH and DBH noted that the success of such facilities has been made possible by coordination between local and federal authorities in Canada, which could present a barrier to implementation in the District of Columbia.

However, the Opioid Working Group is committed to reducing harm and deaths associated with the opioid crisis and will consider what would be required to implement SIFs in D.C. as it develops the Opioid Strategic Plan over the next few months.

You can read the response letter and the original letter sent by Councilmember Grosso below.

DOH/DBH Response to CM Grosso regarding supervised injection facilities by Team_Grosso on Scribd

CM Grosso Letter to DOH on Safe Injection Facilities by Team_Grosso on Scribd

Medical Marijuana Improvement Amendment Act of 2017

Medical Marijuana Improvement Amendment Act of 2017

Introduced: September 19, 2017

Co-introducers: Councilmembers Vincent Gray, Robert White, Brianne K. Nadeau

FACT SHEET | BILL TEXT

Summary: To amend the Legalization of Marijuana for Medical Treatment Initiative of 1998 to increase access to the program by qualified patients by establishing same-day registration and allowing patients to qualify without a doctor’s referral and delivery to patients, establish safe-use treatment facilities to allow consumption outside of the home, allow dispensaries and cultivation centers to relocate and expand operations to meet patient demand, and amend requirements for licensees.

Councilmember Grosso's Introduction Statement:

I am introducing the Medical Marijuana Improvement Amendment Act of 2017, and I thank Councilmembers Gray, Nadeau, and Robert White for joining me as co-introducers.

This legislation, along with the previous bill, will further bolster our responses to the opioid crisis.

Research shows that states with robust medical marijuana programs have lower rates of opioid overdose deaths.

While we have made significant improvements to our medical marijuana program over the past few years, there is more we can do to expand access for patients, and bring more people into the regulated market.

This bill would allow for same day access to medical marijuana just like any other medicine by allowing for a provisional registration when a patient submits their paperwork to the Department of Health.

It would also allow patients who may not have a primary care provider, or whose doctor does not want to recommend medical marijuana, to self-certify that they are seeking medical cannabis.

The bill would allow dispensaries to establish safe use facilities so that patients can consume medical marijuana outside of their home, which would address the challenge that many patients face of having nowhere to consume.

There are a number of other improvements to the program included as well, such as requiring that employees or owners of medical marijuana businesses be D.C. residents, removing the plant count limit, and allowing more residents affected by the war on drugs to be employed in these businesses.

Improving access makes sense when we are in the midst of an opioid overdose crisis, but it also is an appropriate response to the challenges we face as a result of congressional interference with our local efforts to regulate marijuana.

Due to Representative Harris’ rider on our budget, residents are being diverted from the medical marijuana program to the unregulated, easy to access, underground market.

That is posing real problems for the small business owners in the medical marijuana community, and our whole medical marijuana system could be in jeopardy if we don’t take action.
 

Medical Marijuana Improvement Amendment Act of 2017 by Team_Grosso on Scribd

Safe Access for Public Health Amendment Act of 2017

Safe Access for Public Health Amendment Act of 2017

Introduced: September 19, 2017

Co-introducers: Councilmember Vincent Gray

FACT SHEET | BILL TEXT

Summary: To amend Title 25 of the D.C. Official Code to remove possession of certain drug paraphernalia for personal use as a grounds for denial of a license; to amend Title 47 of the D.C. Official Code to remove possession of certain drug paraphernalia for personal use as a grounds for denial of a license; to amend the District of Columbia Uniform Controlled Substances Act of 1981 to remove penalties for possession of certain drug paraphernalia for personal use; to amend the Drug Paraphernalia Act of 1982 to allow possession of certain drug paraphernalia for personal use; and to amend the District of Columbia Appropriations Act of 2001 to remove the prohibition on the operation of needle exchange programs in certain areas of the District.

Councilmember Grosso's Introduction Statement:

I wrote this legislation, along with a bill I will introduce next to improve our medical marijuana program, as a response to the opioid crisis that we face in D.C., much like the rest of the country. 

Last year, we recorded 216 opioid-related deaths, nearly triple the number in 2014.

Meanwhile, we continue to face an HIV epidemic, even as our evidence-based needle exchange programs have dramatically reduced new infections since we were freed from Congress’ prohibition of these life-saving activities. 

This bill takes the next step in those efforts by allowing people to possess drug paraphernalia for personal use.

This is most important for improving access to clean syringes to prevent the spread of HIV and Hepatitis C, but there is also new technology that can save lives in other ways.

Drug testing kits allow people who are using heroin to test the strength of their drugs to avoid overdose, including detecting the presence of fentanyl or carfentanil, the opioids largely responsible for the increase in overdoses.

But these kits would be prohibited as drug paraphernalia under current law.

The Safe Access for Public Health Amendment Act also repeals a congressionally imposed law from years ago that severely restricts the geographical area in which our needle exchange programs can operate.

That law, like so much that Congress forces on us, was not based on any scientific evidence. To the contrary, research shows that the law limits the efficacy of our harm reduction efforts.

We need to consider every evidence-based approach that might help us roll back the tide of overdoses, while also continuing our important progress stopping the spread of HIV and Hepatitis C. 

To that end, today I also sent a letter to Department of Health Director Dr. Nesbitt asking her to examine how D.C. could establish supervised injection sites, where injection drug users could be monitored to prevent overdoses and be connected to treatment.

I hope that Dr. Nesbitt and her team will find a way forward, and that she will also make the overdose prevention medication Narcan more available to our constituents, including by issuing a standing order to allow people to get Narcan over the counter at any pharmacy in the District. 

September is Pain Awareness Month and Overdose Awareness Day just passed on August 31, reminding us of the urgency we must have in our response to these issues. 

Safe Access for Public Health Amendment Act of 2017 by Team_Grosso on Scribd

Grosso proposes bills to deal with opioid crisis, improve public health as Council returns from summer recess

For Immediate Release:
September 19, 2017
 
Contact:
Matthew Nocella, 202.724.8105 - mnocella@dccouncil.us

Grosso proposes bills to deal with opioid crisis, improve public health as Council returns from summer recess

Washington, D.C. – Today Councilmember David Grosso (I-At Large) introduced two bills to address the opioid crisis in the District of Columbia.

“For decades we have attempted to use criminal penalties to solve drug addiction and its associated consequences,” Grosso said.  “This ‘War on Drugs’ has failed and in recent years, D.C. has adopted a public health and evidence-based approach to reduce harm and help people find appropriate treatment.  My proposals continue that approach.”

Last year, D.C. reported 216 opioid-related deaths—nearly triple the number reported in 2014. Grosso’s proposals would remove penalties for possession of certain drug paraphernalia and promote access to the medical marijuana program, both of which have been shown to reduce overdoses.

The Safe Access for Public Health Amendment Act of 2017, allows for access to new technology that enables drug users to test their own drugs to avoid overdosing and supports harm reduction efforts for injection drug use by improving access to clean syringes to reduce the transmission of HIV/AIDS and Hepatitis C.

The bill achieves this greater access by removing criminal penalties for possession for personal use of syringes and drug testing kits, and expanding the areas in which D.C.’s successful needle exchange program can operate.

“There is no scientific basis for criminalizing paraphernalia possession,” Grosso said. “It only increases the likelihood of harm to those who are struggling with addiction and continues the failed policies of the War on Drugs that has had a disproportionate impact on our African-American communities.”

Councilmember Vincent Gray joined Grosso in co-introducing this bill. Grosso joined Gray in co-introducing two other opioid focused bills: Opioid Abuse Treatment Act of 2017 and the Opioid Overdose Prevention Act of 2017.

The Medical Marijuana Improvement Amendment Act of 2017 reduces two major barriers to the city’s medical marijuana program: the requirement for a doctor referral and long wait times to get a registration card.

Under the bill, patients would be granted provisional registration and same-day access to medical marijuana like any other medicine. Patients without a primary care physician, or with one who does not wish to recommend medical marijuana, would be able to self-certify.

“Medical marijuana has been shown to be a viable alternative to the prescription of opioid painkillers, which can set people down the path to addiction,” Grosso said. “While we have made significant improvements to our medical marijuana program here in D.C., there is more we can do to improve access for patients and reduce opioid reliance and overdose.”

A study in JAMA Internal Medicine found that medical marijuana programs reduce opioid overdose death rates by as much as 25 percent.  Americans for Safe Access also reported lower prescription rates of painkillers in states with medical marijuana programs.

Grosso believes D.C. can go even further to combat the opioid crisis.  In a letter sent to Department of Health Director Dr. LaQuandra Nesbitt today, the councilmember asked her to examine how D.C. might set up supervised injection sites where injection drug users could be monitored to prevent overdose and be connected to treatment.  He also believes DOH should find a way to allow Narcan, the opioid overdose prevention medication, to be obtained over-the-counter at any pharmacy in the District of Columbia.

“I hope that Dr. Nesbitt and her team will find a way forward,” Grosso said.

###